BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 04, 2011
 |  BC Week In Review  |  Company News  |  Deals

Apthera, RXi Pharmaceuticals deal

RXi will acquire cancer company Apthera in a stock deal. Apthera shareholders will receive 4.8 million RXi shares, valued at $7.2 million based on RXi's close of $1.50 on March 30, before the deal was announced. Apthera shareholders will own under 20% of the combined company, while RXi shareholders will own...

Read the full 234 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >